Last Price Today's Change   Day's Range   Trading Volume
0.125   0.00 (0.00%)  0.125 - 0.125  0


Avg Volume (4 weeks):134,871
4 Weeks Range:0.11 - 0.22
4 Weeks Price Volatility (%):
52 Weeks Range:0.11 - 0.32
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

AdAlta Limited is an Australia-based drug discovery and development company. The Company is focused on using its technology platform to generate protein therapeutics, known as i-bodies, for treating a range of human diseases. The Company's principal activity is to develop its ibody platform with a focus on its lead candidate AD-114, a treatment for idiopathic pulmonary fibrosis (IPF) and other fibrotic diseases. Its i-body AD-114 drug candidate is used for treatment in various fibrosis related eye diseases to support the pre-clinical development of the eye fibrosis indication. The Company's AD-114 has shown both anti-fibrotic and anti-inflammatory effects in various animal models. The Company's AD-114 is used in various therapeutic applications for fibrosis diseases of the liver, skin, kidney and heart. AD-114 has completed pre-clinical studies in vitro (in the lab) and in vivo (in animals) data obtained.

  Be the first to like this.


616  552  694  9302 

Top 10 Active Counters
 BLY 0.008+0.001 
 APG 0.0010.00 
 BLK 0.012-0.002 
 ADN 0.052-0.006 
 HLS 3.00-0.09 
 CLZ 0.0020.00 
 AMP 1.80+0.02 
 AWC 2.16-0.03 
 TLS 3.78+0.01 
 GLV 0.0030.00 
Partners & Brokers